Profile data is unavailable for this security.
About the company
Flerie AB, formerly InDex Pharmaceuticals Holding AB, is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company is an active long-term global biotech and pharmaceutical investor that managing a portfolio of companies in Europe, Israel, and the US. Flerie invests in companies across the entire value chain, providing exposure to opportunities across three segments: Product Development, Commercial Growth, and Limited Partnerships. The Product Development segment consists of early-stage biotech and pharma companies in product development. The Commercial Growth segment consists of companies that are already selling products or services and showcasing proof-of-concept with high growth and some that have already reached profitability. The Limited Partnerships segment provides benefits for the other two segments, including co-investment opportunities, and derisks Flerie’s investment portfolio.
- Revenue in SEK (TTM)0.00
- Net income in SEK-757.00m
- Incorporated2016
- Employees2.00
- LocationFlerie ABSkeppsbron 16STOCKHOLM 111 30SwedenSWE
- Phone+46 812203850
- Fax+46 850884739
- Websitehttps://www.flerie.com/
More ▼
Mergers & acquisitions
| Acquired company | FLERIE:STO since announced | Transaction value |
|---|---|---|
| Lipum AB | -9.64% | 15.24m |
| Toleranzia AB | -21.14% | 4.53m |
Data delayed at least 15 minutes, as of Feb 16 2026 12:18 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dicot Pharma AB | 126.00k | -84.00m | 640.98m | 4.00 | -- | 7.10 | -- | 5,087.15 | -0.0459 | -0.0459 | 0.00007 | 0.0449 | 0.001 | 10.68 | 0.0371 | 42,000.00 | -69.50 | -94.78 | -75.43 | -111.46 | -61,341.27 | -32,616.05 | -66,663.49 | -37,576.05 | 8.82 | -- | 0.00 | -- | -88.60 | -47.16 | -30.66 | -- | -- | -- |
| Infant Bacterial Therapeutics AB | 0.00 | -79.73m | 734.22m | 10.00 | -- | 6.11 | -- | -- | -5.92 | -5.92 | 0.00 | 9.23 | 0.00 | -- | -- | 0.00 | -38.19 | -22.82 | -48.56 | -24.41 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -11.24 | -- | -- | -- |
| Cinclus Pharma Holding publ AB | 48.42m | -177.05m | 806.03m | 19.00 | -- | 1.91 | -- | 16.65 | -3.80 | -3.80 | 1.04 | 9.07 | 0.0777 | -- | 15.47 | 3,724,539.00 | -28.43 | -- | -32.01 | -- | -- | -- | -365.65 | -- | -- | -- | 0.0197 | -- | -23.14 | -- | 21.89 | -- | -- | -- |
| Vistin Pharma ASA | 427.24m | 73.33m | 883.07m | 77.00 | 12.04 | 3.01 | 9.44 | 2.07 | 1.76 | 1.76 | 10.26 | 7.05 | 1.12 | 1.87 | 6.20 | -- | 19.20 | 1.65 | 23.64 | 1.99 | 66.40 | 62.28 | 17.16 | 1.88 | 1.16 | -- | 0.063 | -- | -1.45 | 13.56 | 37.62 | -1.03 | 17.32 | -- |
| Orexo AB | 386.40m | -201.10m | 940.66m | 72.00 | -- | 1.91 | -- | 2.43 | -5.80 | 18.42 | 11.15 | 14.22 | 0.4073 | 1.29 | 2.02 | 5,366,667.00 | -21.20 | -28.03 | -29.75 | -42.57 | 89.96 | 83.88 | -52.04 | -74.89 | 3.70 | -3.00 | 0.5005 | -- | -12.46 | -47.69 | 15.63 | -- | -- | -- |
| SynAct Pharma AB | 0.00 | -106.27m | 993.01m | 8.00 | -- | 5.10 | -- | -- | -2.20 | -2.20 | 0.00 | 3.65 | 0.00 | -- | -- | 0.00 | -45.16 | -85.38 | -50.22 | -99.19 | -- | -- | -- | -- | -- | -63.96 | 0.0071 | -- | -- | -- | 61.82 | -- | -- | -- |
| Arcticzymes Technologies ASA | 96.82m | 7.19m | 1.07bn | 55.00 | 152.28 | 3.45 | 69.01 | 11.05 | 0.1464 | 0.1464 | 1.97 | 6.47 | 0.2967 | 0.295 | 1.91 | 1,874,073.00 | 2.20 | 13.28 | 2.32 | 14.39 | 95.42 | 96.20 | 7.43 | 31.41 | 15.45 | -- | 0.0184 | 0.00 | -12.26 | 18.22 | -56.40 | -- | 53.98 | -- |
| Photocure ASA | 504.98m | 1.99m | 1.60bn | 101.00 | 779.12 | 3.44 | 54.35 | 3.18 | 0.0809 | 0.0809 | 20.00 | 18.29 | 0.7587 | 1.15 | 8.11 | 5,322,683.00 | 0.2993 | -3.65 | 0.3389 | -4.19 | 92.83 | 94.00 | 0.3945 | -6.26 | 3.87 | -- | 0.00 | -- | 4.94 | 13.29 | -441.16 | -- | 65.53 | -- |
| Flerie AB | 0.00 | -757.00m | 2.68bn | 2.00 | -- | 0.7925 | -- | -- | -9.76 | -9.76 | 0.00 | 43.60 | 0.00 | -- | -- | -- | -19.86 | -18.21 | -19.95 | -18.51 | -- | -367.55 | -- | -1,314.83 | -- | -0.0489 | 0.0006 | -- | -100.00 | -- | -231.97 | -- | -- | -- |
| Swedencare AB (publ) | 2.67bn | 63.00m | 3.93bn | 609.00 | 62.13 | 0.5751 | 10.52 | 1.47 | 0.396 | 0.396 | 16.78 | 42.77 | 0.2788 | 3.63 | 9.86 | 4,776,250.00 | 0.6536 | 1.16 | 0.6795 | 1.20 | 33.60 | 36.00 | 2.34 | 4.40 | 1.52 | 3.94 | 0.2015 | 44.56 | 8.62 | 82.09 | 68.77 | 27.02 | 69.39 | 12.30 |
| BioGaia AB | 1.54bn | 332.76m | 10.21bn | 242.00 | 31.53 | 7.98 | 28.58 | 6.64 | 3.29 | 3.29 | 15.21 | 12.99 | 0.847 | -- | -- | 6,356,066.00 | 18.32 | 15.48 | 20.63 | 16.86 | 73.37 | 73.12 | 21.63 | 26.35 | -- | -- | -- | 133.18 | 8.11 | 15.54 | -5.30 | 13.11 | -25.87 | 24.01 |
| Bonesupport Holding AB | 1.12bn | 151.92m | 11.91bn | 143.00 | 79.02 | 14.44 | 73.35 | 10.64 | 2.29 | 2.29 | 16.83 | 12.52 | 1.26 | 0.6205 | 6.26 | 8,811,984.00 | 17.06 | 5.14 | 20.11 | 6.31 | 92.61 | 91.40 | 13.57 | 5.59 | 3.92 | 19.36 | 0.0133 | 0.00 | 52.05 | 42.04 | -45.41 | -- | 5.71 | -- |
Data as of Feb 16 2026. Currency figures normalised to Flerie AB's reporting currency: Swedish Krona SEK
19.49%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Atlant Fonder ABas of 31 Dec 2024 | 8.13m | 10.49% |
| Fj�rde AP-fondenas of 31 Dec 2024 | 5.46m | 7.05% |
| Handelsbanken Fonder ABas of 31 Dec 2024 | 992.69k | 1.28% |
| SEB Funds ABas of 30 Jan 2026 | 344.09k | 0.44% |
| Storebrand Asset Management ASas of 30 Nov 2025 | 145.34k | 0.19% |
| Skandia Investment Management ABas of 28 Nov 2025 | 21.97k | 0.03% |
| Skandia Fonder ABas of 28 Nov 2025 | 2.23k | 0.00% |
More ▼
Data from 28 Nov 2025 - 30 Jan 2026Source: FactSet Research Systems Inc.
